JAK inhibitors
Are you a clinician? See the clinical version of this page.
These are targeted tablets (not biologics) taken by mouth that block JAK signals inside cells to reduce inflammation. They often work within a couple of weeks. Because of important safety concerns, your team will review your risk factors and do blood tests first.
- Tofacitinib (Xeljanz): A tablet twice a day, or an extended-release tablet once a day.
- Baricitinib (Olumiant): One tablet once a day.
- Upadacitinib (Rinvoq): One tablet once a day.
Tests while you take it
You will have blood tests before and during treatment (blood counts, liver, and cholesterol). Because of heart, blood-clot, and cancer risks seen mainly in older people with heart-disease risk factors, your team will weigh the risks and watch for warning signs.
What to know
Common side effects
These medicines can make some infections more likely, including shingles. They can also change some blood test results, such as cholesterol and blood counts, which is why regular tests are done.
Tests and monitoring
Before you start, your team checks for hidden infections such as tuberculosis, and does baseline blood tests including blood counts, cholesterol, and liver tests. It helps to be up to date with recommended vaccines beforehand, and if you are 50 or older your team may suggest the shingles vaccine before you start. Live vaccines are usually avoided while you are on treatment. Blood tests continue during treatment.
Important cautions
There are important safety points with this group of medicines. In some people, especially older people and those with heart or clot risks, they can raise the risk of blood clots, heart problems, and certain cancers. Your team weighs these with you before choosing one, and they are not right for everyone. Tell your team before any live vaccine.
What to watch for
- Signs of infection, or a painful blistering rash on one side of the body, which can be shingles. Seek care promptly.
- Chest pain, breathlessness, or pain and swelling in a leg, which can be signs of a clot and need urgent care.
- New or changing skin spots or lumps, which should be checked.